- Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis
-
Hyun JW, Kim G, Kim Y, Kong B, Joung A, Park NY, Jang H, Shin HJ, Kim SH, Ahn SW, Shin HY, Huh SY, Kim W, Park MS, Kim BJ, Kim BJ, Oh J, Kim HJ
- KMID: 2407945
- J Clin Neurol.
- 2018 Apr;14(2):186-190.
- doi: 10.3988/jcn.2018.14.2.186
BACKGROUND AND PURPOSE: Patients treated with interferon-beta (IFN-β) can develop neutralizing antibodies (NAbs) against IFN-β that can negatively affect the therapeutic response. This study assessed the prevalence of NAbs and... -
- CITED
-
- Close
- SHARE
-
- Close
- Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta
-
Shin KS, Park JG, Park MS
- KMID: 2153170
- J Korean Neurol Assoc.
- 2016 Feb;34(1):77-79.
- doi: 10.17340/jkna.2016.1.17
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Human Rhinovirus-induced Proinflammatory Cytokine and Interferon-beta Responses in Nasal Epithelial Cells From Chronic Rhinosinusitis Patients
-
Kim JH, Kim YS, Cho GS, Kim NH, Gong CH, Lee BJ, Jang YJ
- KMID: 2147958
- Allergy Asthma Immunol Res.
- 2015 Sep;7(5):489-496.
- doi: 10.4168/aair.2015.7.5.489
PURPOSE: Asthma exacerbation from human rhinovirus (HRV) infection is associated with deficient antiviral interferon (IFN) secretion. Although chronic rhinosinusitis (CRS), an inflammatory upper airway disease, is closely linked to asthma,... -
- CITED
-
- Close
- SHARE
-
- Close
- Combination Therapy for Gliomas Using Temozolomide and Interferon-Beta Secreting Human Bone Marrow Derived Mesenchymal Stem Cells
-
Park JH, Ryu CH, Kim MJ, Jeun SS
- KMID: 1881728
- J Korean Neurosurg Soc.
- 2015 May;57(5):323-328.
- doi: 10.3340/jkns.2015.57.5.323
OBJECTIVE: Malignant gliomas are the most common primary tumors of the central nervous system and the prognosis of patients with gliomas is poor. The combination of interferon-bata (IFN-beta) and temozolomide... -
- CITED
-
- Close
- SHARE
-
- Close
- Chronic Inflammatory Demyelinating Polyneuropathy Developed during Interferon-beta Therapy in a Patient with Multiple Sclerosis
-
Lee CN, Kim BJ, Park KW, Koh SB, Kim HJ, Lee DH
- KMID: 2065613
- J Korean Neurol Assoc.
- 2006 Oct;24(5):486-490.
Preliminary studies have evaluated the effects of interferon beta formulations in the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) because of pathogenic similarities between CIDP and multiple sclerosis (MS). However,... -
- CITED
-
- Close
- SHARE
-
- Close
- Interferon-beta Induced Skin Necrosis
-
Bae GY, Chung YI, Park KI, Lee MW, Moon KC, Koh JK
- KMID: 2362398
- Ann Dermatol.
- 2003 Sep;15(3):119-121.
- doi: 10.5021/ad.2003.15.3.119
Local cutaneous reactions have been reported at injection sites of interferon therapy, but these are usually erythema or rarely induration. Skin necrosis at the injection site is rare. We describe... -
- CITED
-
- Close
- SHARE
-
- Close
- An Analysis of Combined interferon-beta, BCNU and Radiation in the Treatment of Malignant Glioma
-
Kye DK, Park YS, Cho KK, Lee KJ, Park SC, Choi CR
- KMID: 1955058
- J Korean Neurosurg Soc.
- 1995 Dec;24(12):1480-1485.
Prognosis for patients with a malignant glioma of the brain is, up to the present time, very poor. Surgery is unlikely to be curative and the primary goals of the... -
- CITED
-
- Close
- SHARE
-
- Close
